IMUKIN 2 X 106 UI (0,1 mg), solution injectable, SODIUM CHLORIDE
APHP220672
Phase 3 small_molecule active
Quick answer
IMUKIN 2 X 106 UI (0,1 mg), solution injectable, SODIUM CHLORIDE for Post-aggressive immunosuppression is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Post-aggressive immunosuppression
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active